Idiopathic Intracranial Hypertension (IIH) is an underdiagnosed and undertreated disorder of elevated pressure within the brain without an identifiable cause. The IIH Practitioner Series is designed for neurologists, neurosurgeons, neuro-interventionalists, endovascular surgeons, interventionist radiologists, neuroradiologists, ophthalmologists, optometrists, and ENT specialists. Patients and caregivers are always welcome to attend.
Up Next
September 30, 2026
12:00 pm Eastern
Join us on September 30 at 12:00 pm ET for a 30-minute webinar featuring Kenitra W. Dominguez, author of Because I Deserve It, a personal and practical guide to navigating life with a chronic condition.
Diagnosed with idiopathic intracranial hypertension (IIH), Kenitra will share her personal journey and the lessons she has learned about navigating the healthcare system, advocating for herself, and redefining success while living with a chronic condition.
During this conversation, Kenitra will discuss the importance of becoming an informed and empowered advocate for your health, building effective relationships with your healthcare team, navigating systemic barriers to care, and communicating your needs. She will also share her experience requesting workplace accommodations and navigating changes in professional and personal relationships following her diagnosis.
Drawing from her own experience, Kenitra will offer practical perspectives and encouragement for people living with IIH and other chronic conditions.
Kenitra Dominguez is the founder of Bay Equity HR and serves on the Advisory Board of the California Black Women’s Health Project. Her work has been featured in The Washington Post, HuffPost, and Teen Vogue. Her debut book, “Because I Deserve It: What Chronic Illness Taught Me About Finding My Voice in the Healthcare System,” is a memoir and practical guide for patient self-advocacy, aimed at Black women and anyone living with chronic illness. Kenitra’s personal experiences with idiopathic intracranial hypertension (IIH) have shaped her advocacy work and her approach to health equity and patient rights.
Novel neurovascular therapies for idiopathic intracranial hypertension (IIH)
